Efficacy of krypton laser photodynamic therapy for oral mucosa dysplasia in 9,10‑dimethyl‑1,2‑benzanthracene‑treated 
hamsters

Shen,Lingyue; Xu,Qing; Li,Pingping; Zhou,Guoyu

doi:10.3892/ol.2013.1554

November 2013 Volume 6 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November 2013 Volume 6 Issue 5

Full Size Image

Article

Efficacy of krypton laser photodynamic therapy for oral mucosa dysplasia in 9,10‑dimethyl‑1,2‑benzanthracene‑treated hamsters

Authors:
- Lingyue Shen
- Qing Xu
- Pingping Li
- Guoyu Zhou
View Affiliations / Copyright

Affiliations: Department of Oral and Maxillofacial Surgery, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China
Pages: 1358-1362
|
Published online on: August 30, 2013

https://doi.org/10.3892/ol.2013.1554
Expand metrics +

Abstract

The present study aimed to evaluate the efficacy of krypton laser photodynamic therapy (PDT) with PsD‑007 for the treatment of oral mucosa dysplasia in 9,10‑dimethyl‑1,2‑benzanthracene (DMBA)‑treated hamsters. A DMBA‑induced hamster cheek pouch model of precancerous lesions was created and the resultant 25 hamsters were divided into five groups. The right side was treated with PDT and the left side was used as the positive control. Following systemic anesthesia, an incision was made in the groin area to expose the femoral vein. PsD‑007 was administered intravenously through the femoral vein. Various doses of photosensitizer were used to treat groups A‑E. Subsequent to closing the incision, the right side of the buccal mucosa was irradiated with light using the krypton laser at a wavelength of 413 nm, a power density of 150 mW/cm2 and an irradiation time of 20 min. At six weeks post‑surgery, the response was analyzed using histological examinations of the buccal pouch mucosa. A total of 24 hamsters completed the six‑week observation period, as one hamster from group C died in the second week following the PDT. Of all 24 irradiated sides, 15 formed normal mucosal tissues and nine demonstrated mild dysplasia. Of the total control sides, six developed moderate dysplasia, five developed severe dysplasia and 13 progressed to carcinoma in situ or squamous cell carcinoma (SCC). The results revealed a significant difference between the two sides (P<0.01) and the various doses of the PsD‑007 groups. When the PsD‑007 dose was >10 mg/kg, there was no statistical difference (P>0.05). PsD‑007‑mediated krypton laser PDT is effective for the treatment of oral mucosa dysplasia in hamsters.

View Figures

View References

1	Dougherty TJ, Gomer CJ, Herderson BW, et al: Photodynamic therapy. J Natl Cancer Inst. 90:889–905. 1998. View Article : Google Scholar
2	Hopper C, Kubler A, Lewis H, et al: mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer. 111:138–146. 2004. View Article : Google Scholar : PubMed/NCBI
3	Salley JJ: Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J Dent Res. 33:253–262. 1954. View Article : Google Scholar : PubMed/NCBI
4	Eversole LR: Dysplasia of the upper aerodigestive tract squamous epithelium. Head Neck Pathol. 3:63–68. 2009. View Article : Google Scholar : PubMed/NCBI
5	Chen HM, Chen CT, Yang H, et al: Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Oral Oncol. 40:630–637. 2004. View Article : Google Scholar : PubMed/NCBI
6	Gush RJ and King TA: Discrimination of capillary and arterio-venular blood flow in skin by laser Doppler flowmetry. Med Biol Eng Comput. 29:387–392. 1991. View Article : Google Scholar : PubMed/NCBI
7	Tsai JC, Chiang CP, Chen HM, et al: Photodynamic Therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array. Lasers Surg Med. 34:18–24. 2004. View Article : Google Scholar : PubMed/NCBI
8	Biel MA: Photodynamic therapy and the treatment of neoplastic diseases of the larynx. Laryngoscope. 104:399–403. 1994.PubMed/NCBI
9	Kübler A, Haase T, Rheinwald M, et al: Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int J Oral Maxillofac Surg. 27:466–469. 1998.PubMed/NCBI
10	Pariser DM, Lowe NJ, Stewart DM, et al: Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 48:227–232. 2003. View Article : Google Scholar
11	Date M, Sakata I, Fukuchi K, et al: Photodynamic therapy for human oral squamous cell carcinoma and xenografts using a new photosensitizer, PAD-S31. Lasers Surg Med. 33:57–63. 2003. View Article : Google Scholar : PubMed/NCBI
12	Nauta JM, van Leengoed HL, Witjes MJ, et al: Photofrin-mediated photodynamic therapy of chemically-induced premalignant lesions and squamous cell carcinoma of the palatal mucosa in rats. Int J Oral Maxillofac Surg. 26:223–231. 1997. View Article : Google Scholar : PubMed/NCBI
13	Collaud S, Juzeniene A, Moan J and Lange N: On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. Curr Med Chem Anticancer Agents. 4:301–316. 2004. View Article : Google Scholar : PubMed/NCBI
14	Chang SC, Buonaccorsi G, MacRobert AJ and Bown SG: 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration. Lasers Surg Med. 20:254–264. 1997. View Article : Google Scholar : PubMed/NCBI
15	Tsai JC, Chiang CP, Chen HM, et al: Potodynamic therapy of oral dysplasia with topical 5-aminolebulinic acid and light-emitting diode array. Lasers Surg Med. 34:18–24. 2004. View Article : Google Scholar : PubMed/NCBI
16	Kubler A, Haase T, Rheinwald M, et al: Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int J Oral Maxillofac Surg. 27:466–469. 1998. View Article : Google Scholar : PubMed/NCBI